Immune12 researcher at the Southern Cross University, Dr. Janet Schloss, is sharing an abstract, A46JZAJ549, IMMUNE-12 trial for Glioblastoma Patients, at the upcoming 17th COGNO Annual Scientific Meeting (ASM), New Horizons, Novel Therapies to be held Sunday 14 September – Tuesday 16 September 2025 at The Langham Gold Coast, Queensland.
Visit the conference website for more information.